The global AI in cancer diagnostics market is anticipated to grow at a CAGR of 32.5% during the forecast period. Artificial Intelligence (AI) has made positive impact across various sectors including healthcare globally. A notable surge in the adoption of AI tools across different domains, including healthcare, has led to a pronounced increase in demand for AI-driven solutions and services within organizations.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/artificial-intelligence-in-cancer-diagnostics-market
Hence, this rapidly increasing interest has pushed healthcare industries to ramp up investment in AI and Machine Learning (ML)-based solutions, thus spurring growth and development within the market. For an instance, in May-2022, Therapixel launched MammoScreen 2D and 3D, an AI-based software that automatically analyzes mammograms and displays a summary report to radiologists, providing breast cancer detection and using prior exams to refine prediction.
In addition, the growing awareness of early cancer diagnostics drives the growth of AI in cancer diagnostics. The rise in the number of government programs to promote healthcare organizations along with healthcare providers to combine AI technologies in their hospitals for the betterment and advance the therapy of the patients. For instance, in May 2021, Quest Diagnostics and Paige announced a collaboration designed to unlock the potential of artificial intelligence (AI) to improve and speed the diagnosis of cancer and other diseases that rely on pathologic assessment. The collaboration involves analysis using Paige’s proprietary machine learning expertise of pathology diagnostic data and digitized slides from Quest Diagnostics and its AmeriPath and Dermpath businesses to uncover markers of cancer and other diseases. Using these insights, the parties intend to develop new software products which, following regulatory approval, will be marketed to pathologists, oncologists and other providers to support disease diagnosis.
Global Artificial Intelligence in Cancer Diagnostics Market Report Segment
By Application
- Screening & Diagnosis
- Tumor Identification
- Surveillance
By Type
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Colorectal Cancer
- Others (Cervical Cancer, Blood Cancer, Bone Cancer and Other)
By End user
- Hospitals
- Diagnostic Centers
- Research Organization
- Medical Institute and Academics
- Government Healthcare Organizations
A full report of Artificial Intelligence in Cancer Diagnostics Market available @ https://www.omrglobal.com/industry-reports/artificial-intelligence-in-cancer-diagnostics-market
Company Profiles
- Therapixel
- Sophia Genetics SA
- Freenome Holdings, Inc.
- Tempus Labs, Inc.
- Janssen Pharmaceuticals
- Path AI Inc.
- DeepMind Technologies Ltd.
- Cerner Corp.
- RaySearch Laboratories
- Flatiron health
- ai
- Oncology Analytics Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
